Nausea and Vomiting | I & C | Invest in Quality. Contribute to Society.


ProductStrengthPack Size
Aprepitant Tri-Pack Capsules (Atanto)125mg and 80mg3 capsules / box
Ondansetron Tablets (Trondamet)4mg10 tablets / box
30 tablets / box
100 tablets / box
Ondansetron Tablets (Trondamet)8mg10 tablets / box
30 tablets / box
100 tablets / box
* The above product list shows our products which are approved by Hong Kong Department of Health only. It does not mean that all products are already placed in the market. For any product or business enquiries please contact us at or (852) 2891 0581 for further details.

Nausea and Vomiting

Nausea and vomiting is a common adverse effect in cancer treatment. Nausea refers to the unpleasant sensation when one is about to vomit. This might be caused by radiation to gastrointestinal tract, liver or brain or chemotherapy agents that are emetic.

5-HT3 antagonists
Ondansetron is a 5-HT3 antagonist. It is commonly used in chemotherapy-induced nausea and vomiting (CINV), radiotherapy-induced nausea and vomiting (RINV) and post-operative nausea and vomiting (PONV). Common side effects include headache and constipation.

NK-1 antagonists
Aprepitant is an NK-1 antagonist. It is used together with ondansetron and dexamethasone as a combination therapy to prevent nausea and vomiting associated with highly and moderately emetogenic cancer chemotherapy. Aprepitant is supplied in 3-day treatment pack (Tri-Pack) containing one 125 mg capsule and two 80 mg capsules.